Skip to main content

Market Overview

Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

Share:
Crude Oil Edges Lower; Abbott Laboratories Posts Weak Sales

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 250 points on Wednesday.

The Dow traded up 0.27% to 44,146.86 while the NASDAQ rose 1.29% to 20,010.85. The S&P 500 also rose, gaining, 0.70% to 6,091.74.

Check This Out: Top 3 Health Care Stocks That Could Blast Off This Quarter

Leading and Lagging Sectors

Information technology shares surged by 2.5% on Wednesday.

In trading on Wednesday, utilities shares fell by 1.5%.

Top Headline

Abbott Laboratories (NYSE:ABT) reported fourth-quarter sales of $10.97 billion, up 7.2% year over year, missing the consensus of $11.01 billion.

Adjusted diluted earnings per share were $1.34, in line with the analyst estimates and management consensus of $1.31-$1.37, up from $1.19 a year ago.

Abbott projects full-year 2025 adjusted EPS of $5.05-$5.25 versus a consensus of $5.16, with organic sales growth of 7.5%- 8.5% and an adjusted operating margin of 23.5%- 24.0%. Abbott Laboratories expects first quarter 2025 adjusted EPS of $1.05-$1.09 versus consensus of $1.11.

Equities Trading UP
                       

  • Blackboxstocks Inc. (NASDAQ:BLBX) shares shot up 101% to $3.39 after the company announced a $250K securities purchase agreement and is anticipating a potential merger.
  • Shares of Absci Corporation (NASDAQ:ABSI)got a boost, surging 26% to $4.0450 after Needham initiated coverage with a Buy rating and a $9 price target.
  • ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) shares were also up, gaining 30% to $0.6396 after the company announced it developed a new class of GLP-1 therapies using its LENS platform.

Equities Trading DOWN

  • Agilysys, Inc. (NASDAQ:AGYS) shares dropped 21% to $100.00 after the company reported worse-than-expected third-quarter sales results and issued FY25 revenue guidance below estimates.
  • Shares of Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) were down 61% to $0.1265 after the company announced a $9 million public offering.
  • Lisata Therapeutics, Inc. (NASDAQ:LSTA) was down, falling 30% to $2.72 after the company announced preliminary cohort data from its Phase 2 Ascend trial.

Commodities

In commodity news, oil traded down 0.4% to $75.55 while gold traded up 0.4% at $2,770.40.

Silver traded down 0.5% to $31.33 on Wednesday, while copper fell 1% to $4.2985.

Euro zone

European shares were mostly higher today. The eurozone's STOXX 600 surged 0.39%, Germany's DAX 40 rose 1.01% and France's CAC 40 gained 0.86%. Spain's IBEX 35 Index fell 0.37%, while London's FTSE 100 fell 0.04%.

Asia Pacific Markets

Asian markets closed mixed on Wednesday, with Japan's Nikkei 225 gaining 1.58%, China's Shanghai Composite Index falling 0.89%, Hong Kong's Hang Seng Index falling 1.63% and India's BSE Sensex gaining 0.75%.

Economics

U.S. mortgage applications rose 0.1% from the previous week in the week ending Jan. 17.

Now Read This:

 

Related Articles (ABT + ABSI)

View Comments and Join the Discussion!

Posted-In: Earnings Equities News Eurozone Commodities Intraday Update Markets Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com